Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 544 (LINC00544) is a human gene encoding a long non-coding RNA classified as a lincRNA. It does not overlap with any coding genes and is transcribed but not translated into protein. LINC00544 is involved in regulatory processes affecting gene expression, especially in the context of cancer biology, where it has been observed as upregulated in certain cancers and is linked to patient prognosis in osteosarcoma. Like other lincRNAs, its upstream regulatory roles and disease relevance are actively being researched, but it is not currently considered a classical therapeutic target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 544 (LINC00544).